Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adolescence01:18

Cognitive Development During Adolescence

624
During adolescence, individuals experience significant cognitive development that enhances their understanding of others' emotions and thoughts, known as cognitive empathy. This period is marked by an increased ability to adapt to others' perspectives and a more nuanced understanding of others' mental states, a skill that is foundational for social problem-solving and conflict avoidance. The development of cognitive empathy relies heavily on the theory of mind — the...
624
Revisionist Views of Adolescent and Adult Cognition01:24

Revisionist Views of Adolescent and Adult Cognition

311
A revisionist approach to Jean Piaget's theory of cognitive development has brought new insights that challenge and reinterpret his established ideas. Piaget proposed that the formal operational stage, emerging in adolescence, represents the culmination of cognitive maturity. During this stage, individuals are said to develop abstract thinking, engage in systematic problem-solving, and show a form of egocentrism, believing others are as preoccupied with their behavior as they are...
311
Erikson's Theory on Socioemotional Development during Adolescence01:17

Erikson's Theory on Socioemotional Development during Adolescence

1.2K
Erik Erikson's fifth stage of psychosocial development, "identity versus role confusion," is crucial during adolescence (ages 12 to 18). In this stage, adolescents face the developmental task of forging a distinct personal identity, a process influenced by social, psychological, and biological changes typical of this period. Adolescents naturally explore different roles, behaviors, and ideologies as they navigate complex questions of self-concept, asking, "Who am I?" and "What is my place in...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

314
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

237
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New academic year in Headache.

Headache·2026
Same author

Treatment outcomes in new daily persistent headache in children and adolescents.

Cephalalgia : an international journal of headache·2026
Same author

Joint Special Issue: Clinical Otolaryngology and Headache.

Headache·2026
Same author

Joint Special Issue Clinical Otolaryngology and Headache.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2026
Same author

Glucocorticoids for Preventing Migraine Recurrence in the Emergency Department.

JAMA neurology·2026
Same author

Stroke Mimics in Children With Moyamoya Arteriopathy.

Stroke (Hoboken, N.J.)·2026
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Feb 7, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.8K

Pediatric and Adolescent Headache.

Amy A Gelfand

    Continuum (Minneapolis, Minn.)
    |August 4, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric migraine management involves lifestyle changes, acute therapies like triptans, and preventive treatments. About 60% of children and adolescents with migraine improve with this approach.

    More Related Videos

    Chronic Social Defeat Stress in Early Adolescent Male Mice
    07:06

    Chronic Social Defeat Stress in Early Adolescent Male Mice

    Published on: January 24, 2025

    1.6K
    Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
    07:51

    Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

    Published on: August 1, 2025

    1.0K

    Related Experiment Videos

    Last Updated: Feb 7, 2026

    3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
    10:39

    3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

    Published on: June 2, 2014

    18.8K
    Chronic Social Defeat Stress in Early Adolescent Male Mice
    07:06

    Chronic Social Defeat Stress in Early Adolescent Male Mice

    Published on: January 24, 2025

    1.6K
    Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
    07:51

    Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

    Published on: August 1, 2025

    1.0K

    Area of Science:

    • Neurology
    • Pediatrics
    • Headache Medicine

    Background:

    • Headache, particularly migraine, is a common neurological disorder in children and adolescents.
    • Evidence-based guidelines are crucial for effective diagnosis and management.

    Purpose of the Study:

    • To provide neurologists with a comprehensive, evidence-based approach to diagnosing and managing headaches in pediatric populations.
    • To focus specifically on the nuances of migraine treatment in children and adolescents.

    Main Methods:

    • Review of randomized placebo-controlled trials for acute and preventive migraine therapies.
    • Analysis of findings from the Childhood and Adolescent Migraine Prevention trial.
    • Synthesis of current FDA-approved treatments for pediatric migraine.

    Main Results:

    • Approximately 60% of pediatric migraine patients improve with a three-pronged approach: lifestyle counseling, optimal acute therapy (NSAIDs, triptans), and evidence-based preventive treatment.
    • Four triptans are FDA-approved for adolescent acute migraine treatment; rizatriptan is approved for children aged 6+.
    • Clinician judgment is essential for the remaining 40% and those with refractory or medication-overuse headaches.

    Conclusions:

    • A multi-faceted treatment strategy is effective for a majority of pediatric migraine cases.
    • Further research is required for refractory migraines and other primary pediatric headache disorders.
    • Current evidence supports specific acute and preventive therapies, with ongoing needs for more complex cases.